Physician profile

Nader Afgan

Dentist · Glen Burnie, MD

NPI 1760823892

$501.38

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$96.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
A-Dec, INC. $183.00 2021-2022
Dentsply Sirona INC $78.23 2021-2024 Q-Mix, Promark
Straumann USA LLC $60.34 2022-2024
Align Technology, INC. $51.51 2021-2022
Coltene Whaledent INC. $50.00 2020
Philips North America LLC $25.46 2019-2023
3m Company $25.11 2022
Orapharma, A Division of Bausch Health US, LLC $13.91 2019
Sonendo INC $13.82 2023 Gentlewave G4 Console

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Nader Afgan

$501.38

in general payments reported 2019-2025

Years
2019-2024
Top company
A-Dec, INC.

https://glasscript.com/doctor/555595/nader-afgan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.